HAP Trading’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

HAP Trading’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-37,500	Closed	-$29K	–	1786
2022 Q4	$29K	Sell	37,500 -300	-0.8%	-$2.42K	﹤0.01%	863
2022 Q3	$269K	Sell	37,800 -2,500	-6%	-$11.4K	0.02%	514
2022 Q2	$292K	Sell	40,300 -200	-0.5%	-$948	0.01%	582
2022 Q1	$197K	Buy	+40,500	New	+$242K	0.01%	853

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HAP Trading's PRVB Position: Q2 2022 in Review

HAP Trading sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2022, closing a stake of 37,539 shares — an estimated $178K sold.

HAP Trading first reported a position in PRVB in Q1 2022 and held it in 1 quarter. The position peaked at $275K in Q1 2022. 115 funds tracked by Wall St. Rank hold PRVB as of Q2 2022.

HAP Trading reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
HAP Trading sold 37,539 Provention Bio, Inc. Common Stock shares in Q2 2022, an estimated $178K.
HAP Trading first reported a position in Provention Bio, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
HAP Trading's Provention Bio, Inc. Common Stock position peaked at $275K in Q1 2022.
115 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.